According to Taysha Gene Therapies's latest financial reports the company's total assets are $0.17 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | $0.12 B | -40.98% |
2021-12-31 | $0.21 B | -17.35% |
2020-12-31 | $0.25 B | 1725773.33% |
2019-12-31 | $0.01 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.25 B | 45.90% | ๐บ๐ธ USA |